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The reemergence of long-term 
potentiation in aged Alzheimer’s 
disease mouse model
Seonghoo Huh1,*, Soo-Ji Baek1,2,*, Kyung-Hwa Lee3, Daniel J. Whitcomb1,4, Jihoon Jo1,2,5, 
Seong-Min Choi1,5, Dong Hyun Kim6, Man-Seok Park1,5, Kun Ho Lee7 & Byeong C. Kim1,2,5,7
Mouse models of Alzheimer’s disease (AD) have been developed to study the pathophysiology of 
amyloid β protein (Aβ) toxicity, which is thought to cause severe clinical symptoms such as memory 
impairment in AD patients. However, inconsistencies exist between studies using these animal models, 
specifically in terms of the effects on synaptic plasticity, a major cellular model of learning and memory. 
Whereas some studies find impairments in plasticity in these models, others do not. We show that long-
term potentiation (LTP), in the CA1 region of hippocampal slices from this mouse, is impared at Tg2576 
adult 6–7 months old. However, LTP is inducible again in slices taken from Tg2576 aged 14–19 months 
old. In the aged Tg2576, we found that the percentage of parvalbumin (PV)-expressing interneurons in 
hippocampal CA1-3 region is significantly decreased, and LTP inhibition or reversal mediated by NRG1/
ErbB signaling, which requires ErbB4 receptors in PV interneurons, is impaired. Inhibition of ErbB 
receptor kinase in adult Tg2576 restores LTP but impairs depotentiation as shown in aged Tg2576. Our 
study suggests that hippocampal LTP reemerges in aged Tg2576. However, this reemerged LTP is an 
insuppressible form due to impaired NRG1/ErbB signaling, possibly through the loss of PV interneurons.
Progressive loss of memory function and the accumulation of amyloid β protein (Aβ ) in the brain are key char-
acteristics of Alzheimer’s disease (AD) pathology1,2. Previous findings have demonstrated that synaptic plasticity, 
regarded as the cellular basis for learning and memory3, is vulnerable to exposure to high levels of Aβ ; hippocam-
pal long-term potentiation (LTP) is impaired following exogenous exposure to soluble oligomeric Aβ 4–6. To try to 
understand how memory function in AD becomes dysregulated, a vast number of studies have looked to deter-
mine the mechanisms underlying the Aβ -mediated impairment of synaptic plasticity.
To closely model AD pathology, transgenic mice carrying mutant amyloid precursor protein (APP), which 
causes excessive production of Aβ in the brain, have been developed, and are used to investigate the pathophysi-
ology of Aβ toxicity7. However, inconsistencies remain in the pathological readouts from such animals; whether 
LTP is inhibited or normal in these mouse models remains unclear, as notably reported in papers using one of 
the most frequently used transgenic mice harboring the Swedish mutation in APP (APP695SWE)8,9. Here, whilst 
some studies report inhibition of LTP in the APP transgenic mouse10–12, others find no inhibition of LTP between 
3 months and 12 months of age in these AD model mice13–16. An important aspect to consider in relation to this is 
the diverse ages of the animals used in these studies (ranging from 3 to 18 months of age). Here, some studies have 
reported a relationship between abnormal synaptic plasticity and the age of the APP transgenic mouse used, with 
young animals displaying profound LTP impairments that are not present in the older animals15,17. The reason for 
this apparent age-dependent effect, however, is unknown.
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One explanation for these age-dependent effects could relate to the interneuronal control of pyramidal neu-
rons. Most GABAergic interneurons in the hippocampal CA1 region innervate their synapses onto pyramidal 
cell dendrites where neuronal computation, such as modulation, integration of synaptic inputs and expression 
of synaptic plasticity, mainly occurs18–20. Recently, it was shown that loss of GABAergic interneurons leads to an 
enhanced LTP in the hippocampal CA1 region21. Interestingly, a significant decrease in the number of GABAergic 
interneurons was observed in the hippocampus of the AD mouse model and indeed in AD patients22,23. 
Furthermore, enhanced LTP was accompanied with reduced numbers of interneurons in the dentate gyrus of the 
mouse model of both amyloidosis and tauopathy24. One possible explanation, therefore, is that the age-dependent 
loss of GABAergic interneurons in the transgenic mice actually serves to facilitate the induction of LTP in the 
hippocampal CA1 region.
Both ErbB receptor kinases in GABAergic interneurons and the endogenous ligand neuregulin 1 (NRG1), a 
neurotropic factor implicated in neural development, neurotransmission and synaptic plasticity25, have been vari-
ously shown to regulate hippocampal LTP: (1) neutralization of endogenous NRG1 in the hippocampus enhances 
the magnitude of hippocampal LTP at CA1 region26, whereas addition of exogenous NRG1 suppresses the induc-
tion of LTP27,28; (2) inhibition of ErbB4 kinase increases the magnitude of hippocampal LTP, an effect similarly 
observed in ErbB4 knockout mice29,30; (3) ErbB4 is selectively expressed in interneurons but not in pyramidal 
neurons31, and ErbB4 deletion in parvalbumin (PV) interneurons, the major type of GABAergic interneurons 
in hippocampus32,33, completely blocks the LTP regulation induced by NRG126,30. Critically, NRG1 and ErbB4 
distribution was found to be altered in the brains spotted with neuritic plaques in the mouse model of AD and 
in AD patients34. We therefore hypothesized that the age-dependent dysregulation of hippocampal LTP in the 
APP transgenic mouse was underpinned by the Aβ -mediated impairment of NRG1/ErbB signaling, leading to 
the facilitation of LTP. Here we demonstrate a possible link between a loss of interneurons, NRG1/ErbB signaling 
dysregulation and changes in synaptic plasticity in a mouse model of AD.
Results
The reemergence of LTP in the hippocampus of aged Tg2576. To examine whether LTP in Tg2576 
mice is altered in an age-dependent manner, we compared LTP in two different age groups, 6–7 months old 
(adult) and 14–19 months old (aged), in the hippocampal CA1 region. Tg2576 is a well-documented mouse 
model of AD showing high levels of Aβ and memory impairment8,10, and soluble Aβ in the brains of these 
transgenic animals begins to be significantly accumulated at around 6 months of age after a non-accumulation 
phase from birth11,35. Increased fEPSP induced by high frequency stimulation (HFS) at the Schaffer collateral 
pathway was maintained for 2 hours in adult littermate WT, but returned to baseline levels in adult Tg2576 
(Tg: 113.2 ± 7.4% of baseline, n = 8, closed circle; WT: 159.1 ± 9.4%, n = 8, open circle, P < 0.01 Fig. 1A), which is 
consistent with reports describing impaired LTP in Tg2576 of similar ages12,15. In contrast, the increased fEPSPs 
Figure 1. The reemergence of LTP in the hippocampus of aged Tg2576. (A) Applying two trains of tetanus 
stimuli (10 Hz in  s, 3 s inter-train interval) to the Schaffer collateral pathway evoked LTP in the hippocampal 
CA1 region in 6–7 months old WT (open circle, n = 8) but did not in Tg2576, where the fEPSP was gradually 
decreased to the baseline level 2 hours after LTP induction by HFS (closed circle, n = 8). (B) In 14–19 months 
old animals, LTP was observed in both WT (open circle, n = 7) and Tg2576 (closed circle, n = 7) mice, and their 
increased fEPSP levels were not significantly different (P > 0.05). Error bars represent standard error of the 
mean (SEM). fEPSP = field excitatory postsynaptic potential.
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were maintained until 2 hours after HFS application in aged Tg2576, and there were no significant differences in 
the levels of the potentiated fEPSPs between the aged Tg2576 and littermate WT mice (Tg: 181.7 ± 12.0%, n = 7, 
closed circle; WT: 164.8 ± 7.2%, n = 7, open circle, P > 0.05, Fig. 1B). Interestingly, the observed time period 
for LTP inhibition and reappearance in Tg2576 mice is very similar to a previous report which pointed out that 
soluble Aβ levels in the brain was not correlated with the LTP deficit in aged animals15. Clearly, then, there is an 
interesting disparity in impaired synaptic plasticity in these AD mouse models; whilst LTP is inhibited at early 
ages after soluble Aβ accumulation begins, it reemerges at older ages.
Decreased percentage of PV interneurons in hippocampal CA region of aged Tg2576. One 
possible explanation for the LTP reemergence in aged Tg2576 would be the decreased density of inhibitory 
interneurons in hippocampus, which could conceivably contribute to an enhancement of excitatory signaling 
and the facilitation of LTP. To test this hypothesis, we specifically measured the percentage of PV interneurons 
in hippocampal CA1-3 region. PV interneurons constitute a major proportion of GABAergic interneurons in 
the hippocampus32,33. Further, PV interneurons are critical for the NRG1/ErbB4-mediated down-regulation of 
LTP expression at the Schaffer collateral-CA1 synapse26,30. PV-immunoreactive (IR) neurons were observed in 
hippocampus of both the adult and aged Tg2576 (Fig. 2A,B). To calculate the percentage of PV interneurons, 
NeuN and PV-IR neurons were counted in whole CA subfields, and the ratio of PV-IR to NeuN-IR cells was 
estimated. We found that the proportion of PV interneurons to NeuN-positive cells was significantly decreased in 
aged Tg2576 compared with adult Tg2576 (Fig. 2C). Importantly, this reduction was not solely due to the aging 
effect, since there was no significant difference in the percentage of the neurons between adult and aged littermate 
WT. Interestingly, it was recently shown that loss of PV interneurons is associated with enhanced LTP in a mouse 
model of multiple sclerosis36, suggesting a strong possibility of this neuronal loss enhancing LTP in aged Tg2576.
NRG1-induced LTP inhibition and depotentiation are impaired in aged Tg2576. We next tested 
whether the regulation of synaptic plasticity by NRG1/ErbB signaling is intact in aged Tg2576. Previous studies 
Figure 2. The percentage of parvalbumin (PV) interneurons is reduced in aged Tg2576. (A) Representative 
PV immunohistochemistry stains in the hippocampus of a 6–7 months old (adult) WT (n = 4) and Tg2576 
(n = 4) mouse. PV-positive interneurons are shown in the hippocampus at a low magnification (original 
magnification, × 40), and at a closer distance from the CA1 (original magnification, × 100, pointed by 
arrowheads) and CA3 (original magnification, × 100). (B) Representative PV immunohistochemistry stains 
in the hippocampus of a 14–19 months old (aged) WT (n = 6) and Tg2576 (n = 6) mouse. (C) The ratio of PV-
positive cells to NeuN-positive cells (data not shown) in aged Tg2576 is significantly lower than in adult Tg2576 
(* * P < 0.01, * * * * P < 0.0001).
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demonstrated that perfusion of hippocampal slices with recombinant NRG1 peptide inhibits the induction of 
hippocampal LTP by activating ErbB4 receptor kinase in PV interneurons26,30. We first measured hippocampal 
LTP in 2–4 months old (young) Tg2576, in which Aβ is produced only marginally in the brain35, and littermate 
WT. We found that LTP was readily induced in both age groups (Tg: 185.5 ± 11.2%, n = 7, closed circle; WT: 
177.4 ± 10.3%, n = 7, open circle, P > 0.05, Fig. 3A). We next investigated the NRG1-induced LTP inhibition using 
those mice, by measuring fEPSP in hippocampal slices perfused with 1 nM NRG1 peptide, stimulated with HFS 
20 minutes after onset of NRG1 perfusion. The NRG1 perfusion readily suppressed the induction of LTP in both 
young Tg2576 and littermate WT (Tg vehicle: 166.9 ± 13.6%, n = 7, grey closed circle; WT vehicle: 187.0 ± 17.0%, 
n = 6, grey open circle; Tg NRG1: 98.4 ± 6.4%, n = 6, maroon closed circle, P < 0.01 compared with Tg vehicle; 
WT NRG1: 111.0 ± 3.7%, n = 6, maroon open circle, P < 0.01 compared with WT vehicle, Fig. 3B). We then tested 
the integrity of NRG1-induced LTP inhibition in aged Tg2576 and littermate WT. Interestingly, we found that 
NRG1 perfusion inhibited LTP induction in aged WT, but did not in aged Tg2576 (Tg vehicle: 179.0 ± 15.3%, 
n = 5, grey closed circle; WT vehicle: 170.2 ± 16.1%, n = 6, grey open circle; Tg NRG1: 175.6 ± 14.1%, n = 6, 
maroon closed circle, P > 0.05 compared with Tg vehicle; WT NRG1: 112.7 ± 4.4%, n = 6, maroon open circle, 
P < 0.05 compared with WT vehicle, Fig. 3C). These data suggest that an NRG1/ErbB-mediated signaling path-
way that can suppress LTP does not function normally in aged Tg2576 in which LTP reappears after the deficit 
period at adult age.
NRG1/ErbB signaling is known to be involved in depotentiation, another form of synaptic plasticity where 
LTP can be reversed by a specific form of synaptic activity induced within a few minutes following LTP induc-
tion37,38. It has been shown that the application of NRG1 peptide or theta-pulse stimulation (TPS), a low fre-
quency stimulation that is widely used to induce depotentiation37, reverses previously induced hippocampal 
LTP, and ErbB4 in PV interneurons is crucial for this effect30,39. To examine whether depotentiation is intact 
in both young and aged Tg2576, we applied TPS to the Schaffer collateral pathway in the hippocampus 5 min-
utes after HFS application. We found that potentiated fEPSPs by HFS application returned to the baseline at 
1.5 hours after applying TPS in both young Tg2576 and littermate WT, indicative of a depotentiation of synapses 
(Tg: 118.3 ± 7.0%, n = 7, closed circle; WT: 103.8 ± 8.3%, n = 6, open circle, P > 0.05, Fig. 3D). LTP was also 
readily depotentiated by the application of TPS in aged littermate WT, but remained at an elevated level 2 hours 
after applying TPS in aged Tg2576 (Tg: 178.4 ± 13.7%, n = 6, closed circle; WT: 104.7 ± 5.0%, n = 6, open circle, 
P < 0.01, Fig. 3E). The absence of depotentiation in slices from aged Tg2576 animals is consistent with NRG1/
ErbB signaling being impaired in aged Tg2576, and suggests that synaptic function in aged Tg2576 is abnor-
mal in spite of the reemergence of LTP. We also observed that, in both Tg2576 and WT mice, the expression of 
NRG1 and ErbB4 in the hippocampus was not significantly different among 3 age groups (P > 0.05). However, 
this data showed that the expression of ErbB4 tended to decrease in Tg2576 in comparison with littermate WT 
(Tg: 78 ~ 82%, n = 5, closed bar, P > 0.05, Fig. 3F).
Inhibition of ErbB receptor kinase in adult Tg2576 can mimic the changes of the synaptic plas-
ticity in aged Tg2576. If the impaired NRG1/ErbB signaling is actually correlated with the reemerged LTP 
in aged Tg2576 mice, disrupting NRG1/ErbB signaling in adult Tg2576 might induce similar synaptic charac-
teristics to those observed in aged Tg2576: normal LTP but impaired depotentiation. We therefore investigated 
the effect of blocking the ErbB4 receptor on synaptic plasticity in adult Tg2576. To do this, we first perfused 
hippocampal slices from adult Tg2576 with 10 μ M PD158780, an inhibitor of ErbB receptor kinase, for 10 min-
utes starting 2 minutes before HFS application. LTP was induced in PD158780 treated slices, and the potentiated 
fEPSP was maintained for more than 2 hours (Tg vehicle: 108.8 ± 8.8%, n = 6, grey closed circle; WT vehicle: 
146.4 ± 6.7%, n = 3, grey open circle; Tg PD158780: 154.6 ± 3.9%, n = 6, maroon closed circle, P < 0.01 compared 
with Tg vehicle, WT PD158780: 176.2 ± 2.8%, n = 6, maroon open circle, P < 0.05 compared with WT vehicle, 
Fig. 4A). Interrupting endogenous NRG1/ErbB signaling by PD158780 is also known to enhance the level of fEP-
SPs at already potentiated synapses39. We therefore tested whether PD158780 perfusion after LTP induction could 
rescue the LTP deficit in adult Tg2576. Perfusion of 10μ Μ PD158780 for an hour after LTP induction increased 
the level of diminishing LTP and the re-potentiated fEPSPs were maintained for another 2 hours (Tg PD158780: 
168.7 ± 16.1%, n = 6, closed circle, Fig. 4B). Therefore, disrupted NRG1/ErbB signaling might be sufficient to 
induce LTP in aged Tg2576 as impaired LTP was rescued in adult Tg2576 upon the perfusion of PD158780 at 
both HFS induction and an hour followed by the induction. In addition, we measured TPS-induced depotentia-
tion in conjunction with 10 minutes PD158780 perfusion begun 2 minutes before HFS application. We found that 
LTP could not be depotentiated by the TPS application in the PD158780 treated slices (Tg vehicle: 120.2 ± 8.5%, 
n = 5, grey closed circle; Tg PD158780: 200.5 ± 30.4%, maroon closed circle, n = 6, P < 0.05, Fig. 4C) but readily 
depotentiated in littermate WT mice (WT: 120.6 ± 5.6%, n = 5, open circle, Fig. 4D). These data suggest that the 
inhibition of NRG1/ErbB signaling in adult Tg2576 is sufficient to mimic the characteristics of hippocampal 
synaptic plasticity in aged Tg2576.
Deficits in memory function in aged Tg2576. To assess whether learning and memory function changed 
during ageing in Tg2576 animals, we conducted a novel object recognition memory test. In all experimental con-
ditions, total exploration time was not different between groups (training, Fig. 5A; test, Fig. 5B). However, the dis-
crimination index indicates impaired object recognition memory in both groups of 6 month- and 13 month-old 
Tg2576 mice. Novel object recognition memory performance declined progressively during aging in Tg2576 mice 
compared with WT littermate mice (Fig. 5C).
Discussion
In this study, we have shown that the number of PV interneurons is significantly reduced in the hippocampus 
of the aged Tg2576. Critically, we reveal that NRG1/ErbB4 signaling-mediated LTP regulation, TPS-induced 
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Figure 3. NRG1-induced LTP inhibition and TPS-induced depotentiation are impaired in aged Tg2576. 
(A) LTP was readily induced in both 2–4 months old WT (open circle, n = 7) and Tg2576 (closed circle, n = 7) 
mice. (B) Perfusion of  nM NRG1 peptide during the period indicated by the heavy line suppressed LTP in 
both 2–4 months old WT (maroon open circle, n = 6), and Tg2576 (maroon closed circle, n = 6). (C) NRG1 
perfusion also suppressed LTP in 14–19 months old WT (maroon open circle, n = 6), but did not in Tg2576 
(maroon closed circle, n = 6) (D) Applying theta pulse stimulation (TPS, 100 pulses with  Hz) 5 minutes after 
HFS reversed LTP in both 2–4 months old WT (open circle, n = 6) and Tg2576 (closed circle, n = 7). (E) TPS 
also reversed LTP in 14–19 months old WT (open circle, n = 6), but did not in Tg2576 (closed circle, n = 6).  
(F) In both Tg2576 and WT mice, the expression of NRG1 and ErbB4 in the hippocampus was not significantly 
different among 3 aged groups (P > 0.05). However, this data showed that the expression of ErbB4 tended to 
decrease in Tg2576 (closed bar, n = 5) in comparison with littermate WT (open bar, n = 5) at each aged group. 
Two-way ANOVA and Turkey’s multiple comparison tests were used for the statistical analysis of this data. 
Error bars represent SEM. fEPSP = field excitatory postsynaptic potential.
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depotentiation and NRG1-induced LTP suppression, for which PV interneurons are essential, are impaired in 
the aged Tg2576. An inhibitor of the ErbB receptor prevented the LTP deficit but blocked TPS-induced depo-
tentiation in the adult Tg2576, suggesting that the disrupted NRG1/ErbB signaling would be a strong candidate 
for the cause of the LTP reemergence in aged Tg2576. Our results may contribute to a potential answer to the 
controversy over whether LTP is inhibited10–12 or normal13–16 in the transgenic mouse model of AD (expressing 
APPswe mutation): LTP is only hindered for a certain period of time and then reappears in spite of concomitant 
behavioral deficits at that time, but the revived LTP is still abnormal due to the lack of inhibitory control and is 
accompanied by learning and memory deficits. Accordingly, this could account for the observed LTP found in 
certain AD transgenic mice13–16; LTP is indeed inducible, but the fundamental molecular mechanisms respon-
sible for its induction and expression have actually changed. Indeed, evidence suggests that LTP impairment is 
associated with behavioral deficits but the degree of LTP impairment is not related to the accumulation of Aβ and 
age from 3 to 12 months16.
Among the observed changes in aged Tg2576, loss of interneurons in the AD brain has attracted many inves-
tigators’ attention to examine the physiological consequences of the cell loss and its relevance to AD. Several 
studies reported that GABAergic interneurons are more vulnerable to the toxic oligomeric Aβ than pyramidal 
neurons23,40, and are observed to degenerate in the transgenic mouse model of tauopathy41 or both amyloidosis 
and tauopathy24, as well as in human apolipoprotein E4 knock-in mouse42 and in AD patients22. Interneuron 
degeneration in the AD mouse models led to alterations in synaptic plasticity24,41, stereotypic hyperactivity24, 
inhibited sensory motor gating41, and impaired learning and memory41,42. In addition, recent studies have shown 
that both hormonal intervention and transplantation of interneuron progenitors to prevent or replace GABAergic 
interneuronal loss in AD mouse models could restore memory and prevent cognitive dysfunctions which are usu-
ally observed in the transgenic mice43,44. Thus, loss of interneurons is a relatively established pathological change 
and a direct cause of cognitive and behavioral abnormalities in AD. Our finding that PV interneurons degenerates 
in the hippocampus of aged Tg2576 showing abnormal synaptic plasticity also supports this notion.
On the other hand, the relationship between NRG1/ErbB signaling and AD has just started to be examined. 
NRG1/ErbB signaling has recently been implicated in several neuropsychiatric disorders, such as schizophre-
nia and bipolar disorder, because of its importance in development and function of neural circuitry, relevant to 
behavioral deficits and genetic association with those diseases45. There was also a polymorphism study suggesting 
that the NRG1 gene is associated with AD46, (though see47). Some recent studies reported that, in the brains of 
both human and AD mouse models, expression levels of NRG1 and ErbB4 were changed48,49 and the distribution 
Figure 4. ErbB inhibitor restores LTP but blocks depotentiation in adult Tg2576. (A) Perfusion of 10 μ M 
PD158780, an inhibitor of ErbB, for 10 minutes starting two minutes before HFS, as indicated by the heavy line, 
restored LTP in 6–7 months old Tg2576 (maroon closed circle, n = 6), and enhanced LTP in 6–7 months old 
wild-type (maroon open circle, n = 6). (B) Perfusion of PD158780 for 10 minutes starting an hour after HFS 
increased fEPSP slope, which was continuously decreased just before, and the re-potentiated fEPSP slope was 
maintained for another two hours. (closed circle, n = 6) (C) TPS did not reverse LTP in the hippocampal slices 
from 6–7 months old Tg2576 perfused with PD158780 (closed circle, n = 6). (D) TPS readily reversed LTP in 
6–7 months old WT slices (open circle, n = 5). Error bars represent SEM. fEPSP = field excitatory postsynaptic 
potential.
www.nature.com/scientificreports/
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of those proteins in the hippocampus was altered along accumulated neuritic plaques34. However, further inves-
tigation is required to determine whether changes in NRG1 and ErbB expression actually contribute to the pro-
gression of AD. Interestingly, some studies have shown that pathophysiological features of AD can be remedied by 
modulating NRG1/ErbB4 signaling; treatment of NRG1 in APP/PS1 transgenic mice inhibits neuronal apoptosis 
in APP/PS1 transgenic mice via ErbB4-dependent PI3-kinase/Akt pathway activation49, and also prevents soluble 
Aβ 1-42-induced LTP impairment via ErbB4 activation50. Collectively, therefore, although there are still only lim-
ited studies, NRG1 and ErbB kinases may play an important role in AD and other neurodegenerative disorders. 
In accordance with this, we also showed that NRG1/ErbB signaling was interrupted in the aged AD mouse model, 
as treatment of NRG1 did not suppress LTP in hippocampus of the aged Tg2576. This may be due to loss of PV 
interneurons, as NRG1 suppress LTP via activating ErbB4 receptor kinase in the specific neuron. We found that 
the percentage of PV interneurons in hippocampal CA region of aged Tg2576 was only about 70% of the percent-
age in adult Tg2576 and 50% in aged littermate WT. A direct relationship, however, between disruption of NRG1/
ErbB4 signaling and loss of PV interneuron in aged AD mouse models, should be investigated in future studies.
Lastly, as far as we know, activity-dependent depotentiation in AD mouse model has not been previously 
measured. Along with LTP and long-term depression (LTD), depotentiation has been regarded as another impor-
tant type of synaptic plasticity38. Acting as a counterbalance to the potential saturation of synaptic potentiation, 
depotentiation may contribute to synaptic homeostasis by which synaptic strength is maintained at a set level to 
be changeable by subsequent neuronal activity. In addition, depotentiation has been shown to play an impor-
tant role in the refinement of developing neural circuits51, storage of novel spatial information52 and fear mem-
ory extinction in amygdala53. Clearly, then, depotentiation plays a critical role in normal physiological function. 
In this study, we observed that depotentiation could not be induced in aged Tg2576. This means that synaptic 
memory is still ablated in the aged Tg2576 in spite of the reemergence of LTP. Given that it has been suggested 
that depotentiation is related to specific neurological diseases and involves molecular mechanisms distinct from 
LTP and LTD54, it is reasonable to assume that Tg2576 would exhibit different behavioral phenotypes at specific 
ages when LTP and depotentiation emerge dysregulated. Indeed, previous reports suggest that aged human APP 
transgenic mice exhibited behavioral abnormalities such as hyperactivity55–58 and deficits in sensorimotor gat-
ing measured by prepulse inhibition (PPI)59, which are similar to those shown in the transgenic animals where 
depotentiation was not induced and NRG1/ErbB signaling impaired30. Such activity disturbance and PPI deficits 
are also observed in AD patients60,61. However, further study is needed to directly demonstrate the relationship 
between impaired depotentiation and the behavioral abnormalities in Tg2576 or other AD mouse models, such 
as the deficits in learning and memory paradigms like those we demonstrate here. This will give us further insight 
into the behaviorally relevant synaptic level changes occurring during the development of AD pathology. In sum-
mary, our three new findings of reduced proportion of hippocampal PV interneurons, disruption of NRG1/ErbB4 
signaling and impaired depotentiation, in aged Tg2576, might shed light on the underlying pathological changes 
altering synaptic memory during the progress of AD.
Methods
Materials. Recombinant human NRG1-beta1 epidermal growth factor (EGF) domain (R&D Systems, #396-
HB-050) was reconstituted in sterile PBS containing 0.1% bovine serum albumin (Sigma, #A3294). ErbB receptor 
kinase inhibitor PD158780 (Calbiochem, #513035) was dissolved at 10 mM in DMSO for stock solution.
Figure 5. Object recognition memory in adult Tg2576. Habituation training was conducted for 3 days by 
exposing the animal to the experimental apparatus for 10 min per day in the absence of objects for the indicated 
number of days. The training session was conducted 24 h following the last habituation training. During the 
training session, mice were placed in the experimental apparatus in the presence of two identical objects 
and allowed to explore for 10 min. After a retention interval of 24 h, mice were again placed in the apparatus; 
however, one of the objects was replaced with a novel one. Mice were allowed to explore for 10 min. (A) Total 
exploration time in training session. (B) Total exploration time in test session. (C) Discrimination index in test 
session. Adult Tg2576 (Tg) mice displayed a significant reduction in object recognition memory compared with 
wild-type (WT) mice (24.3 vs 39.1 at 6 months, 16.7 vs 35.2 at 13 months). Data are presented as mean ± S.E.M. 
* P < 0.05 (n = 7–10/group, t-test).
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Animals. All experimental protocols were approved by the Institutional Animal Care and Use Committee 
of Chonnam National University. The methods were carried out in accordance with the approved guidelines. 
Tg2576 male mice were received from Taconic (USA, #1349) and crossbred with hybrid B6SJLF1 (from Taconic) 
female mice. The offspring, heterozygous transgenic and littermate wild type (WT) male mice, were used. The 
mice were housed in individual ventilated cages (IVC) with access to water and food ad libitum, under a 12 h 
light/12 h dark cycle.
Hippocampal slice preparation. Animals were sacrificed with cervical dislocation and decapitated. The 
brain was rapidly removed and one hemisphere was directly placed into ice-cold artificial cerebrospinal fluid 
(aCSF) containing 124 mM NaCl, 3 mM KCl, 26 mM NaHCO3, 1.25 mM NaH2PO4, 2 mM CaCl2, 1 mM MgSO4 
and 10 mM D-Glucose, perfused with gas consisting of 95% O2 and 5% CO2. The other hemisphere was used for 
immunohistochemistry. The hippocampus was extracted and transverse hippocampal slices (40 μ m thickness) 
were cut using a McIllwain tissue chopper (Mickle Laboratory Engineering Co.). Following manual separation, 
the slices were submerged in aCSF for a minimum of 1 hour for recovery before experiments commenced.
Electrophysiology. Hippocampal slices were placed into the recording chamber, continuously perfused with 
oxygenated aCSF flowing at a rate of at  ml min−1, maintained at a temperature of 29–30 °C. For recording, two 
stimulating electrode were positioned on Schaffer collateral pathway (for LTP and depotentiation input) and 
subiculum region (for control input) respectively, to produce field excitatory postsynaptic potentials (fEPSP). 
Recording glass pipettes were prepared by a micropipette puller (Sutter Instrument, P-1000) and filled with  M 
NaCl. The recording glass pipettes were fixed and controlled by a micromanipulator, used to locate the recording 
electrode to the CA1 region of the hippocampus. Following the acquisition of a stable baseline for 30 minutes, 
two trains of tetanus stimuli (100 Hz for 1 second with 30 seconds inter-tetanus interval) were applied to induce 
LTP. Depotentiation was induced with theta pulse stimulation (5 Hz for 1 minute) 5 minutes following the induc-
tion of LTP. Data acquisition and analysis was performed using WinLTP (www.winltp.com). Briefly, the slope of 
the evoked fEPSPs was measured, normalized to the pre-conditioning baseline and expressed as a percentage of 
baseline.
Western blot analysis. Hippocampal slices were homogenized, lysed and immediately snap frozen. Protein 
samples were separated according to their size on sodium dodecyl sulfate (SDS)-polyacrylamide gels and trans-
ferred to PVDF membranes (Millipore, USA). The membranes were probed with primary antibodies against 
NRG1 (Abcam, #ab53104) and ErbB4 (Thermo Scientific Pierce, #MAI-861) overnight and then probed with 
secondary antibodies conjugated to horseradish peroxidase for an hour. Immunoreactive bands were detected 
using an ECL detection system (LAS-3000, FUJIFILM, Japan). Optical densities of the band were quantified using 
ImageJ software (http://rsbweb.nig.gov/ij/).
Immunohistochemistry. Mouse hemispheric brains were fixed in 10% neutral-buffered formalin for 3 
days. Brains were dissected, embedded in paraffin, and stained with hematoxylin for histopathological evaluation. 
Tissue blocks were sliced at a thickness of 4 μ m for immunohistochemistry. Each unstained slide was stained with 
specific antibodies against Parvalbumin (Product No. PA1-933, 1:1000, ThermoFisher, Rockford, IL, USA) and 
NeuN (Product No. MAB377, 1:100, Merck Millipore, Darmstadt, Germany) using an automated immunostainer 
(Bond-maX DC2002, Leica Biosystems, Bannockburn, IL, USA). Programmed heat-induced epitope retrieval 
was carried out using bond epitope retrieval solution 1 (containing Tris EDTA, pH 9.0) for Parvalbumin antibody 
and bond epitope retrieval solution 2 (containing Ethylenediaminetetraacetic acid (EDTA) buffer at pH 9.0) for 
NeuN antibody. Negative controls were processed similarly in the absence of primary antibodies.
Object recognition memory test. The experimental apparatus consisted of a black polyvinyl plastic 
square open field (45 cm × 45 cm × 45 cm). Habituation training was conducted for 3 days by exposing the ani-
mal to the experimental apparatus for 10 min per day in the absence of objects for the indicated number of days. 
The training session was conducted 24 h following the last habituation training. During the training session, 
mice were placed in the experimental apparatus in the presence of two identical objects and allowed to explore 
for 10 min. After a retention interval of 24 h, mice were again placed in the apparatus; however, one of the objects 
was replaced with a novel one. Mice were allowed to explore for 10 min. The objects chosen for this experiment 
included a plastic orange and wooden trigonal prism, both approximately the same height. The durations of time 
mice spent exploring each object (familiar object, Tfamiliar; novel object, Tnovel) were recorded. The discrimination 
index was calculated by following formula: (Tnovel −  Tfamiliar)/(Tnovel + Tfamiliar) × 100.
Data analysis. Data were analyzed from one slice per mouse (n = number of slices = number of mice). In 
electrophysiology, the fEPSP slope was expressed as the mean ± SEM (standard error of the mean) and relative 
to a normalized baseline. For the comparison of LTP and depotentiation between groups, fEPSPs at the end of 
recording were used. An unpaired two-tailed Student’s t-test was used for the statistical analysis of the electro-
physiology data and novel object recognition tests, and two-way ANOVA and Turkey’s multiple comparison 
tests for the Western blotting and immunohistochemistry data. All statistical calculations were performed using 
GraphPad Prism (GraphPad Software Inc.).
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